Skip to content Skip to navigation

FDA Approves Ingestible Digital Sensor that Tracks Medication Adherence

August 2, 2012
by Gabriel Perna
| Reprints

The U.S. Food and Drug Administration (FDA) has approved of an ingestible digital sensor that is used to transmit patient data to track medication adherence, according to a press release from the company that is marketing the device. The company, Redwood City, Calif.-based Proteus Digital Health, Inc., announced that the ingestible sensor, referred to as the Ingestion Event Marker, has been approved by the FDA after the company worked with the agency for several years to determine a regulatory pathway.

“We are thrilled to have achieved this important milestone to market our ingestible sensor in the United States now, as well as in Europe,” Dr. George M. Savage, co-founder and chief medical officer at Proteus Digital Health, said in a statement. “We are very much looking forward to bringing the benefits of our ingestible sensor to the American public in the form of innovative product offerings.”

The device, which is a part of the Proteus digital health feedback system that aims to improve patients’ health habits and connections to caregivers, is already approved in Europe. The pill is as small as a grain of sand and can be integrated into an inert pill or other ingested products, such as pharmaceuticals. According to Proteus, once the sensor reaches the stomach, it is powered by contact with stomach fluid and communicates a unique signal that determines identity and timing of ingestion.

The information is then transferred through the user’s body tissue to a patch worn on the skin, which detects the signal and marks the precise time an ingestible sensor has been taken, Proteus says. It relays the information to a mobile phone app. This is all done with the patient’s permission. Cost has not yet been determined.



CMS Hospital Compare Website Updated with VA Data

The Centers for Medicare & Medicaid Services (CMS) has announced the inclusion of Veterans Administration (VA) hospital performance data as part of the federal agency’s Hospital Compare website.

CMS Awards Funding to Special Innovation Projects

The Centers for Medicare & Medicaid Services (CMS) has awarded 20, two-year Special Innovation Projects (SIPs) aimed at local efforts to deliver better care at lower cost.

Center of Excellence in Genomic Science to be Established in Chicago

The National Human Genome Research Institute has awarded $10.6 million over five years for the establishment of a new research center in Chicago to advance genomic science.

EHNAC and HITRUST Combine HIPAA Security Criteria, CSF Framework

The Electronic Healthcare Network Accreditation Commission (EHNAC) and the Health Information Trust Alliance (HITRUST) announced plans to streamline their accreditation and certification programs.

Halamka on MACRA Final Rule: “CMS is Listening and I Thank Them”

Health IT notable expert John Halamka, M.D., CIO of Beth Israel Deaconess Medical Center in Boston, recently weighed in on the Medicare Access and CHIP Reauthorization Act (MACRA) final rule.

Texas Patient Care Clinic Hit with Ransomware Attack

Grand Prairie, Texas-based Rainbow Children's Clinic was the victim of a ransomware attack on its IT systems in August, affecting more than 33,000 patients, according to multiple news media reports this week.